Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS, MRCP(UK)
Internal Medicine Specialist
M.B.B.S., M.C.P.S (Family Medicine)
Diabetologist
M.B.B.S, Dip. in Diabetes
Endocrinologist
MBBS, MCPS, MRCGP
Internal Medicine Specialist
M.B.B.S
Cardiologist
MBBS, FCPS
Endocrinologist
M.B.B.S, FCPS-Medicine (Aga Khan University), Fellowship in Diabetes and Endocrinology (Aga Khan university), FCPS Endocrinology
Endocrinologist
M.B.B.S, FCPS-Medicine (Aga Khan University), Fellowship in Diabetes and Endocrinology (Aga Khan university), FCPS Endocrinology
Diabetologist
MBBS, Dip. In Diabetes, P.G , HA & MAMS , C.R.C.P
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures